It's just business: Manufacturing moves from Eaton, IPS, JR Automation, and more

As manufacturers strive to optimize and improve profitability, they often use various business strategies to stay competitive. These actions include mergers, acquisitions, promotions, layoffs, funding, and much more. Below are just a few of the companies that are making moves and making headlines in the industrial sector.

Partnership: Eaton announced a collaboration with Xendee Corporation to deliver integrated microgrid solutions that combine Eaton’s power distribution technologies with Xendee’s AI-powered modeling and operations platform. The partnership aims to help customers design, deploy, and operate resilient, cost-effective microgrids and distributed energy resources, while also accelerating the adoption of AI in energy management. In a recent quote, Angie McMillin, president of Energy Solutions and Services at Eaton, said, “Together with Xendee, we’re unlocking new ways to help customers maximize the functionality and value of their microgrid investments across North America and Europe. We’re confident that uniting Eaton’s proven microgrid expertise, intelligent power management solutions and services with Xendee’s advanced digital optimization technology will better position microgrid operators to seize the opportunities created by the energy transition.” 
Learn more

Acquisition: Integrated Power Services (IPS) has acquired CFM Services, a NETA-certified field service power company based in St-Jean-sur-Richelieu, Québec, to strengthen its portfolio in Canada. CFM serves customers across the province with solutions for high- and medium-voltage systems, transformer refurbishment, and electrical services in industries including hydropower, government, utilities, and education. In a recent quote, Shannon Moses, Executive Vice President & General Manager, IPS Power Management Division, said, “CFM is a dynamic NETA-certified field service power company in Québec, delivering comprehensive solutions, with a focus on high and medium voltage systems and reconditioning and refurbishment of transformers.” 
Learn more

Relocation: JR Automation will establish its new global headquarters in Zeeland, Michigan, with a $72.8 million investment that is expected to create 150 new jobs and consolidate three existing Michigan sites. The new facility will include both office and manufacturing space, support nearly 1,000 current Michigan employees, and feature sustainability measures such as solar panels and renewable energy use. In a recent quote, Kevin Klynstra, Mayor of Zeeland, said, “We are very proud to welcome JR Automation to the city of Zeeland. To have them pick our community is an honor. We have been known to be a business-friendly community for many years, and we have given many tax abatements out to industrial and commercial businesses over the years. We hope to have a long and successful relationship with JR Automation.” 
Learn more

Partnership: USAntibiotics announced a collaboration with Walmart and McKesson, through ClarusONE Sourcing Services, to provide domestically manufactured amoxicillin to pharmacies and healthcare providers across the United States. The partnership will deliver millions of doses, supporting Walmart’s U.S. manufacturing investment goals and McKesson’s efforts to strengthen the national healthcare supply chain. In a recent quote, Patrick Cashman, president of USAntibiotics, said, “We are thrilled to work with Walmart and McKesson to bring domestically manufactured antibiotics directly to American families. We extend our deepest gratitude to Walmart and McKesson for their leadership in supporting U.S. manufacturing of critical generic medicines. This collaboration represents more than a business relationship – it's a commitment to America’s health security.” 
Learn more

Partnership: Made Scientific and Hemogenyx Pharmaceuticals announced a manufacturing partnership to advance HG-CT-1, Hemogenyx’s CAR-T therapy currently in a Phase I clinical trial for relapsed/refractory acute myeloid leukemia in adults. The collaboration will utilize Made Scientific’s GMP facilities in Newark and Princeton, New Jersey, to support clinical manufacturing and potential expansion to pediatric patient cohorts. In a recent quote, Syed T. Husain, Chairman & CEO of Made Scientific, said, “Our collaboration with Hemogenyx reflects Made Scientific's commitment to advancing next-generation cell therapies that address urgent, unmet medical needs. Through our integrated development and manufacturing solutions and highly experienced team, we are proud to support Hemogenyx as they advance HG-CT-1 in their Phase I clinical trial.” 
Learn more